Anti-PKD1/ PBP/ PC1 monoclonal antibody

Anti-PKD1/ PBP/ PC1 antibody for FACS & in-vivo assay

Target products collectionGo to PKD1/PKD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1374-Ab-1/ GM-Tg-hg-MP1374-Ab-2Anti-Human PKD1 monoclonal antibodyHuman
GM-Tg-rg-MP1374-Ab-1/ GM-Tg-rg-MP1374-Ab-2Anti-Rat PKD1 monoclonal antibodyRat
GM-Tg-mg-MP1374-Ab-1/ GM-Tg-mg-MP1374-Ab-2Anti-Mouse PKD1 monoclonal antibodyMouse
GM-Tg-cynog-MP1374-Ab-1/ GM-Tg-cynog-MP1374-Ab-2Anti-Cynomolgus/ Rhesus macaque PKD1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1374-Ab-1/ GM-Tg-felg-MP1374-Ab-2Anti-Feline PKD1 monoclonal antibodyFeline
GM-Tg-cang-MP1374-Ab-1/ GM-Tg-cang-MP1374-Ab-2Anti-Canine PKD1 monoclonal antibodyCanine
GM-Tg-bovg-MP1374-Ab-1/ GM-Tg-bovg-MP1374-Ab-2Anti-Bovine PKD1 monoclonal antibodyBovine
GM-Tg-equg-MP1374-Ab-1/ GM-Tg-equg-MP1374-Ab-2Anti-Equine PKD1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1374-Ab-1/ GM-Tg-hg-MP1374-Ab-2; GM-Tg-rg-MP1374-Ab-1/ GM-Tg-rg-MP1374-Ab-2;
GM-Tg-mg-MP1374-Ab-1/ GM-Tg-mg-MP1374-Ab-2; GM-Tg-cynog-MP1374-Ab-1/ GM-Tg-cynog-MP1374-Ab-2;
GM-Tg-felg-MP1374-Ab-1/ GM-Tg-felg-MP1374-Ab-2; GM-Tg-cang-MP1374-Ab-1/ GM-Tg-cang-MP1374-Ab-2;
GM-Tg-bovg-MP1374-Ab-1/ GM-Tg-bovg-MP1374-Ab-2; GM-Tg-equg-MP1374-Ab-1/ GM-Tg-equg-MP1374-Ab-2
Products NameAnti-PKD1 monoclonal antibody
Formatmab
Target NamePKD1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PKD1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PKD1/ PBP/ PC1 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1374
    Target NamePKD1
    Gene ID5310,18763,24650,694905,606755,100144606,504986,100068126
    Gene Symbol and SynonymsmFLJ00285,PBP,Pc-1,PC1,PKD1,TRPP1
    Uniprot AccessionP98161
    Uniprot Entry NamePKD1_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000008710
    Target ClassificationTumor-associated antigen (TAA)

    The target: PKD1, gene name: PKD1, also named as PBP, PC1, Pc-1, TRPP1. This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.